Exchange Traded Concepts’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
VCM
BTW
Exchange Traded Concepts's AMPH Position: Q1 2026 in Review
Exchange Traded Concepts increased its Amphastar Pharmaceuticals (AMPH) stake by 775% in Q1 2026, buying an estimated $1.79M and bringing the position to 82,416 shares worth $1.61M. The position accounts for 0.01% of the portfolio, ranked #657.
Exchange Traded Concepts first reported a position in AMPH in Q3 2020 and has held it in 18 quarters since. The position peaked at $2.65M in Q2 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Exchange Traded Concepts held 82,416 shares of Amphastar Pharmaceuticals worth $1.61M as of Q1 2026.
- Exchange Traded Concepts bought 72,998 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $1.79M.
- Amphastar Pharmaceuticals made up 0.01% of Exchange Traded Concepts's portfolio in Q1 2026, its #657 holding.
- Exchange Traded Concepts first reported a position in Amphastar Pharmaceuticals in Q3 2020 and has held it in 18 quarters since.
- Exchange Traded Concepts's Amphastar Pharmaceuticals position peaked at $2.65M in Q2 2023.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.